Bimuno Clinical Trials

Bimuno is the result of many years of intensive research conducted in collaboration with the University of Reading's Food Microbial Sciences Unit and globally recognized research institutes.

The research is headed by the Professor of Food Microbiology at the University of Reading, Professor Glenn Gibson. A highly regarded specialist in the field of prebiotics, Professor Gibson is responsible for leading a multi-disciplinary research programme in gut microbiology, primarily related to the bacteriology of human health and disease.

The result of this research was the development of a second generation galacto-oligosaccharide prebiotic (Bimuno) which specifically targets and feeds your beneficial bacteria, energising your immunity boosting Bifidobacteria, whilst reducing the levels of harmful bacteria.

This work was initially achieved using a laboratory model of the human colon in order to identify the most effective natural food for the beneficial bacteria of the gut. A number of clinical trials have been completed and subsequent trials will continue to be the focus of ongoing research in this very exciting area which positively affects all our lives.

Download Bimuno Published Papers

A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers' diarrhoea

A mixture containing galactooligosaccharide, produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium infection in mice.

Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers

Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study

The effects of a transgalactoolisgosaccharide prebiotic on fecal microbiota and symptoms in irritable bowel syndrome.

A novel galacto-oligosaccharide mixture increases the bifidobacterial population numbers in a continuous in-vitro fermentation system and in proximal colonic contents of pigs in-vivo.

Bimuno Process Development

Bimuno Synthesis.